Hu H - Search Results

1

A deep learning model based on MRI for prediction of vessels encapsulating tumour clusters and prognosis in hepatocellular carcinoma.

Yang J, Dong X, Wang F, Jin S, Zhang B, Zhang H, Pan W, Gan M, Duan S, Zhang L, Hu H, Ji W. Yang J, et al. Among authors: hu h. Abdom Radiol (NY). 2024 Apr;49(4):1074-1083. doi: 10.1007/s00261-023-04141-3. Epub 2024 Jan 4. Abdom Radiol (NY). 2024. PMID: 38175256

2

Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization by CalliSpheres^® in 275 Hepatocellular Carcinoma Patients: Results From the Chinese CalliSpheres^® Transarterial Chemoembolization in Liver Cancer (CTILC) Study.

Sun J, Zhou G, Xie X, Gu W, Huang J, Zhu D, Hu W, Hou Q, Shi C, Li T, Zhang X, Ji W, Ying S, Peng Z, Zhou J, Yu Z, Ji J, Du H, Guo X, Fang J, Han J, Xu H, Sun Z, Yu W, Shao G, Wu X, Hu H, Li L, Zheng J, Luo J, Chen Y, Cao G, Hu T. Sun J, et al. Among authors: hu t, hu h, hu w. Oncol Res. 2020 Feb 7;28(1):75-94. doi: 10.3727/096504019X15662966719585. Epub 2019 Sep 26. Oncol Res. 2020. PMID: 31558180 Free PMC article. Clinical Trial.

3

The Comprehensive Analysis of Efficacy and Safety of CalliSpheres^® Drug-Eluting Beads Transarterial Chemoembolization in 367 Liver Cancer Patients: A Multiple-Center, Cohort Study.

Peng Z, Cao G, Hou Q, Li L, Ying S, Sun J, Zhou G, Zhou J, Zhang X, Ji W, Yu Z, Li T, Zhu D, Hu W, Ji J, Du H, Shi C, Guo X, Fang J, Han J, Gu W, Xie X, Sun Z, Xu H, Wu X, Hu T, Huang J, Hu H, Zheng J, Luo J, Chen Y, Yu W, Shao G. Peng Z, et al. Among authors: hu t, hu h, hu w. Oncol Res. 2020 May 29;28(3):249-271. doi: 10.3727/096504019X15766663541105. Epub 2019 Dec 19. Oncol Res. 2020. PMID: 31856933 Free PMC article.

4

Drug-eluting beads transarterial chemoembolization by CalliSpheres is effective and well tolerated in treating intrahepatic cholangiocarcinoma patients: A preliminary result from CTILC study.

Luo J, Zheng J, Shi C, Fang J, Peng Z, Huang J, Sun J, Zhou G, Li T, Zhu D, Xu H, Hou Q, Ying S, Sun Z, Du H, Xie X, Cao G, Ji W, Han J, Gu W, Guo X, Shao G, Yu Z, Zhou J, Yu W, Zhang X, Li L, Hu H, Hu T, Wu X, Chen Y, Ji J, Hu W. Luo J, et al. Among authors: hu t, hu h, hu w. Medicine (Baltimore). 2020 Mar;99(12):e19276. doi: 10.1097/MD.0000000000019276. Medicine (Baltimore). 2020. PMID: 32195932 Free PMC article.

5

No staghorn calculi and none/mild hydronephrosis may be risk factors for severe bleeding complications after percutaneous nephrolithotomy.

Dong X, Wang D, Zhang H, You S, Pan W, Pang P, Chen C, Hu H, Ji W. Dong X, et al. Among authors: hu h. BMC Urol. 2021 Aug 13;21(1):107. doi: 10.1186/s12894-021-00866-9. BMC Urol. 2021. PMID: 34388999 Free PMC article.

6

Efficacy and safety of CalliSpheres^® drug-eluting beads transarterial chemoembolization in patients with secondary liver cancer: a preliminary result from CTILC study.

Wu X, Ying S, Huang J, Shi C, Ji J, Peng Z, Zhou G, Sun Z, Sun J, Yu W, Hu W, Zhang X, Zhou J, Shao G, Yu Z, Hou Q, Gu W, Li T, Xie X, Cao G, Du H, Zhu D, Xu H, Han J, Ji W, Fang J, Li L, Zheng J, Luo J, Chen Y, Hu T, Hu H, Guo X. Wu X, et al. Among authors: hu t, hu h, hu w. Transl Cancer Res. 2019 Aug;8(4):1199-1216. doi: 10.21037/tcr.2019.06.44. Transl Cancer Res. 2019. PMID: 35116862 Free PMC article.

7

Prediction of Response to Induction Chemotherapy Plus Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma Based on MRI Radiomics and Delta Radiomics: A Two-Center Retrospective Study.

Xi Y, Ge X, Ji H, Wang L, Duan S, Chen H, Wang M, Hu H, Jiang F, Ding Z. Xi Y, et al. Among authors: hu h. Front Oncol. 2022 Apr 22;12:824509. doi: 10.3389/fonc.2022.824509. eCollection 2022. Front Oncol. 2022. PMID: 35530350 Free PMC article.

8

CT-Based Radiomics for the Recurrence Prediction of Hepatocellular Carcinoma After Surgical Resection.

Wang F, Chen Q, Zhang Y, Chen Y, Zhu Y, Zhou W, Liang X, Yang Y, Hu H. Wang F, et al. Among authors: hu h. J Hepatocell Carcinoma. 2022 May 23;9:453-465. doi: 10.2147/JHC.S362772. eCollection 2022. J Hepatocell Carcinoma. 2022. PMID: 35646748 Free PMC article.

9

A novel multimodal deep learning model for preoperative prediction of microvascular invasion and outcome in hepatocellular carcinoma.

Wang F, Chen Q, Chen Y, Zhu Y, Zhang Y, Cao D, Zhou W, Liang X, Yang Y, Lin L, Hu H. Wang F, et al. Among authors: hu h. Eur J Surg Oncol. 2023 Jan;49(1):156-164. doi: 10.1016/j.ejso.2022.08.036. Epub 2022 Sep 6. Eur J Surg Oncol. 2023. PMID: 36333180

10

Deep learning for predicting major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer: A multicentre study.

She Y, He B, Wang F, Zhong Y, Wang T, Liu Z, Yang M, Yu B, Deng J, Sun X, Wu C, Hou L, Zhu Y, Yang Y, Hu H, Dong D, Chen C, Tian J. She Y, et al. Among authors: hu h. EBioMedicine. 2022 Dec;86:104364. doi: 10.1016/j.ebiom.2022.104364. Epub 2022 Nov 14. EBioMedicine. 2022. PMID: 36395737 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,047 results

Search Page

Filters